Clinical Trial Update: T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Conditioned With a Reduced Intensity Regimen in Patients With Hematologic Malignancies and Aplastic Anemia [Phase 1]

View source ↗

Summary

Phase 1 study evaluating T cell-depleted allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in patients with hematologic mal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Hematologic Malignancies

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Myeloid Diseases | Phase 1 | Status: ACTIVE_NOT_RECRUITING